a needle-free nasal spray influenza vaccine for self-administration. "EMA CHMP recommends AstraZeneca’s Fasenra to treat EGPA ...

"This mismatch can cause problems affecting both the patient who will receive the IV injection and the nurse who will give the IV medication. The softening IV needle aims to overcome the current ...

A needle-free injection will soon be available to thousands of diabetics. A British company has designed a £120 gadget that could free diabetics from the daily trauma of painful injections.

Gentle nasal spray vaccines against COVID, the flu and RSV are coming. They may work better than shots in the arm ...

AstraZeneca bioPharmaceuticals business unit executive vice-president Ruud Dobber stated: “Today’s approval of Fasenra, with its convenient, single-monthly injection, is a positive step ...

This liquid needle penetrates the surface of the skin and delivers the medications into the subcutaneous fatty tissue of the injection site. The product consists of a re-usable needle-free injector, ...

The European Commission has approved the Committee for Medicinal Products for Human Use (CHMP) recommendation to change the terms of marketing authorization for Fasenra (benralizumab). It can now ...

Today’s approval of Fasenra, with its convenient, single-monthly injection is a positive step forward for patients with EGPA. Fasenra has been a well-established treatment for many years in thousands ...

AstraZeneca’s (AZN) Fasenra has been approved in the European Union, EU, as an add-on treatment for adult patients with relapsing or refractory eosinophilic granulomatosis with polyangiitis ...

IntegriMedical has launched India's first Needle-Free Injection System to ease the pain of injections for children and adults, enhancing healthcare experiences. Check into any pediatrician’s ...

5,7 Patients were randomized to receive either a single 30 mg subcutaneous injection of FASENRA, or three separate 100 mg subcutaneous injections of mepolizumab every four weeks.4,5 In the trial, ...